Generalized tetanus despite prior vaccination and a protective level of anti-tetanus antibodies

American Journal of the Medical Sciences

Volumn 339, Issue 2, 2010, Pages 200-201

  Livorsi, Daniel J ^a   Eaton, Molly ^a   Glass, Jonathan ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Generalized tetanus; Protective antibody; Vaccination

Indexed keywords

BACLOFEN; BENZODIAZEPINE; METRONIDAZOLE; TETANUS ANTIBODY;

ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; DISEASE CONTROL; ELECTROMYOGRAPHY; HUMAN; LUMBAR PUNCTURE; MALE; MUSCLE SPASM; NERVE CONDUCTION; TETANUS; TETANUS PROPHYLAXIS; TREATMENT OUTCOME;

EID: 77049093025     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181c2f534     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. Notifiable disease/ deaths in selected cities weekly information. MMWR Morb Mortal Wkly Rep 2009;58:783.
2. Pickering JW, Martins TB, Schroder MC, et al. Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for quantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae type b. Clin Diag Lab Immunol 2002;9:872-876
3. Boyd JS. Tetanus in the African and European theatres of war. Lancet 1946;247:113-119
4. Trujillo MJ, Castillo A, EspaÑa JV, et al. Tetanus in the adult: intensive care and management experience with 233 patients. Crit Care Med 1980;8:419-423
5. Edmondson RS, Flowers MW. Intensive care in tetanus: management, complications, and mortality in 100 cases. Br Med J 1979;1:1401-1404
6. Patel JC, Mehta BC. Tetanus: study of 8,697 cases. Indian J Med Sci 1999;53:393-401.
7. Scheibel I. The uses and results of active tetanus immunization. Bull World Health Organ 1955;13:381-394
8. Yeni P, Carbon C, Tremolieres F, et al. Serum levels of antibody to toxoid during tetanus and after specific immunization of patients with tetanus. J Infect Dis 1982;145:278.
9. Berger SA, Cherubin CE, Nelson S, et al. Tetanus despite preexisting antitetanus antibody. JAMA 1978;240:769.
10. Passen EL, Andersen BR. Clinical tetanus despite a protective level of toxin-neutralizing antibody. JAMA 1986;255:1171-1173
11. Crone N, Reder AT. Severe tetanus in immunized patients with high anti-tetanus titers. Neurology 1992;42:761-764
12. Pryor T, Onarecker C, Coniglione T. Elevated antitoxin titers in a man with generalized tetanus. J Fam Pract 1997;44:299-303.
13. Abrahamian FM, Pollack CV Jr, LoVecchio F, et al. Fatal tetanus in a drug abuser with "protective" antitetanus antibodies. J Emerg Med 2000;18:189-193
14. de La Chapelle A, Lavabre O, Pinsard M, et al. Tetanus in a renal transplant recipient exhibiting the presence of circulating antitetanus antibodies by ELISA. Biomed Pharmacother 2002;56:208-210
15. Beltran A, Go E, Haq M, et al. A case of clinical tetanus in a patient with protective antitetanus antibody level. South Med J 2007;100:83.
16. Goulon M, Girard O, Grosbuis S, et al. Antitetanus antibodies: assay before anatoxinotherapy in 64 tetanus patients. Nouv Presse Med 1972;1:3049-3050
17. Maselle SY, Matre R, Mbise R, et al. Neonatal tetanus despite protective serum antitoxin concentration. FEMS Microbiol Immunol 1991;3:171-175
18. de Moraes-Pinto MI, Oruamabo RS, Igbagiri FP, et al. Neonatal tetanus despite immunization and protective antitoxin antibody. J Infect Dis 1995;171:1076-1077
19. Owa JA, Makinde OO. Neonatal tetanus in babies of women immunized with tetanus toxoid during pregnancy. Trop Doct 1990;20:156-157
20. Sneath P, Kerslake EG, Scruby F. Tetanus immunity: the resistance of guinea pigs to lethal spore doses induced by active and passive immunization. Am J Hyg 1937;25:464-476